Diagnostic Performance of Smart Supra Perimetry (The DPSSP Study)

Sponsor
Manchester University NHS Foundation Trust (Other)
Overall Status
Recruiting
CT.gov ID
NCT03978546
Collaborator
University of Manchester (Other), Columbia University (Other)
100
1
2
33.3
3

Study Details

Study Description

Brief Summary

Early glaucomatous visual field changes can be missed with the routinely used Standard Automated Perimetry (SAP) and the 24-2 test pattern due to limited sampling of the central 10 degrees. While this shortcoming can be overcome with the addition of a 10-2 test, performing both tests places extra demand on the perimetric services (doubling test times) and patients.

Smart Supra Perimetry (SSP) uses a new faster algorithm that can complete both 24-2 and 10-2 test patterns in a similar time frame to a single 24-2 SAP test. This comparative study aims to determine the sensitivity and specificity (i.e. diagnostic accuracy) of SSP in identifying early glaucomatous visual field loss. A sample of 100 patients with early/suspect glaucoma will undergo SAP 24-2 and 10-2 (SITA algorithm) using Humphrey visual field perimetry and SSP 24+10-2 using Henson 9000. Eyes will be categorised into 2 groups i.e., glaucoma and non-glaucoma, on the basis of structural changes to the disc as evaluated by the clinician. The sensitivity and specificity of the SAP and SSP tests will be established along with test duration. The size and location of defects established with both the SAP and SSP strategies will also be compared.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Humphrey Visual Field Test
  • Diagnostic Test: Optical Coherence Tomography (OCT) Scan
  • Diagnostic Test: Smart Perimetry - Henson 9000
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Intervention Model Description:
All participants will have the same examinations but in a randomised order, these examinations are: Humphrey Visual Fields Test (10-2 and 24-2, SITA Standard), OCT Scan (Cube scan, Wide angle and macula scan) and Smart Perimetry - Henson 9000.All participants will have the same examinations but in a randomised order, these examinations are: Humphrey Visual Fields Test (10-2 and 24-2, SITA Standard), OCT Scan (Cube scan, Wide angle and macula scan) and Smart Perimetry - Henson 9000.
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Diagnostic Performance of Smart Supra Perimetry (SSP) in Comparison With Standard Automated Perimetry (SAP) and Ocular Coherence Tomography (OCT).
Actual Study Start Date :
Jun 20, 2019
Anticipated Primary Completion Date :
Mar 31, 2022
Anticipated Study Completion Date :
Mar 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Non-Glaucoma Patient Arm

All participants will complete the same assessments

Diagnostic Test: Humphrey Visual Field Test
SITA Standard and 24-2 and 10-2 visual field tests

Diagnostic Test: Optical Coherence Tomography (OCT) Scan
Circle and Wide Angle Scans

Diagnostic Test: Smart Perimetry - Henson 9000
24+10-2 Smart Supra test

Experimental: Glaucoma Patient Arm

All participants will complete the same assessments

Diagnostic Test: Humphrey Visual Field Test
SITA Standard and 24-2 and 10-2 visual field tests

Diagnostic Test: Optical Coherence Tomography (OCT) Scan
Circle and Wide Angle Scans

Diagnostic Test: Smart Perimetry - Henson 9000
24+10-2 Smart Supra test

Outcome Measures

Primary Outcome Measures

  1. Diagnostic performance of smart supra perimetry [12 months]

    Area under the curve for Smart Suprathrold Perimetry using probability thresholds to differentiate early glaucoma from non-glaucomatous visual fields.

Secondary Outcome Measures

  1. Diagnostic performance of Optical Coherent Tomography [12 months]

    Sensitivity and specificity for Optical Coherent Tomography in the detection of early glaucoma.

  2. Diagnostic performance of Standard Automated perimetry [12 months]

    Sensitivity and specificity for Standard Automated perimetry in the detection of early glaucoma.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Reliable SAP visual field results (fixation loss < 33%, false positive < 15% and false negative < 20%).

  • Visual acuity better or equal to 0.20 logMAR.

  • Spherical refractive error within -6.00 to +6.00D and cylindrical error <2.00D

  • No ocular co-morbidity likely to affect the visual field or OCT results.

  • Age: 40-80 yrs

Additional inclusion criteria for glaucomatous group:
  • Optic disc showing glaucomatous changes.

  • SAP MD not worse than -6dB

Additional inclusion criteria non-glaucoma group:
  • Normal SAP visual field data (MD, PSD, GHT within normal range)

  • No evidence of glaucoma or other Ocular co-morbidity in the eye suitable for the study.

Exclusion Criteria:
Exclusion criteria glaucomatous and control groups:

• Anomalous discs, Tilted discs, myopic discs.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Manchester Royal Eye Hospital Manchester United Kingdom M13 9WL

Sponsors and Collaborators

  • Manchester University NHS Foundation Trust
  • University of Manchester
  • Columbia University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Manchester University NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT03978546
Other Study ID Numbers:
  • 250459
First Posted:
Jun 7, 2019
Last Update Posted:
Mar 24, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Manchester University NHS Foundation Trust
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 24, 2022